Showing results (1271-1280 of 2,566) with videos related to

Sort By:
Pageof 257
Drug Testing and Analysis|February 6, 2021
Comprehensive characterization of the peroxisome proliferator activated receptor-δ agonist GW501516 for horse doping control analysisStéphane Trevisiol, Yves Moulard, Vivian Delcourt, et al.
Drug Testing and Analysis|January 17, 2022
Application of single hair analysis in a doping case involving amphetamineChristopher Wiedfeld, Gisela Skopp, Detlef Thieme, et al.
Drug Testing and Analysis|February 28, 2014
An investigation of the stability of emerging new psychoactive substancesYan Ni Annie Soh, Simon Elliott
Drug Testing and Analysis|February 28, 2014
Prospective evaluation of potential toxicity of repeated doses of Thymus vulgaris L. extracts in rats by means of clinical chemistry, histopathology and NMR-based metabonomic approachFouzia Benourad, Zehra Kahvecioglu, Mokhtar Youcef-Benkada, et al.
Drug Testing and Analysis|February 28, 2014
The syntheses, characterization and in vitro metabolism of nitracaine, methoxypiperamide and mephtetramineJohn D Power, Kenneth R Scott, Elizabeth A Gardner, et al.
Drug Testing and Analysis|February 28, 2014
Characterizing metabolites and potential metabolic pathways for the novel psychoactive substance methoxetamineE L Menzies, S C Hudson, P I Dargan, et al.
Drug Testing and Analysis|February 28, 2014
Enantioselective disposition of (R/S)-albuterol in skeletal and cardiac muscleGlenn A Jacobson, Kwang Choon Yee, Dino Premilovac, et al.
Drug Testing and Analysis|March 26, 2014
HILIC-UPLC-MS/MS combined with hierarchical clustering analysis to rapidly analyze and evaluate nucleobases and nucleosides in Ginkgo biloba leavesXin Yao, Guisheng Zhou, Yuping Tang, et al.
Drug Testing and Analysis|March 26, 2014
Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuseOlof Beck, Linnea Rausberg, Yasir Al-Saffar, et al.
Drug Testing and Analysis|February 19, 2014
Drug-drug interaction and doping, part 2: an in vitro study on the effect of non-prohibited drugs on the phase I metabolic profile of stanozololMonica Mazzarino, Xavier de la Torre, Ilaria Fiacco, et al.
Pageof 257